V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260011192 | 260007100 | 1.7 | 73 | Curative (C) | 2016-08-14 | 2016-08-14 | Rituximab (Maintenance) | N | N | 260020066 | RITUXIMAB |
| 260011193 | 260007101 | 1.68 | 98.6 | Palliative (P) | 2015-12-10 | 2015-12-11 | Rituximab | 99 | N | 260020075 | RITUXIMAB |
| 260011194 | 260007101 | null | 0 | Palliative (P) | 2014-01-04 | 2014-02-04 | Rituximab (Maintenance) | N | N | 260020075 | RITUXIMAB |
| 260011195 | 260013018 | 1.76 | 90 | Disease modification (D) | 2014-10-15 | 2014-10-25 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260020079 | RITUXIMAB |
| 260011196 | 260013018 | null | 89.4 | Disease modification (D) | 2017-05-10 | 2017-05-10 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260020079 | RITUXIMAB |
| 260011197 | 260013018 | 1.81 | 93 | Disease modification (D) | 2013-05-18 | 2013-10-06 | Rituximab | 02 | N | 260020079 | RITUXIMAB |
| 260011198 | 260007103 | 1.8 | 63.8 | Adjuvant (A) | 2015-05-30 | 2015-06-02 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260020087 | RITUXIMAB |
| 260011199 | 260007103 | 1.86 | 70.9 | Disease modification (D) | 2017-02-17 | 2017-03-04 | Rituximab | 02 | N | 260020087 | RITUXIMAB |
| 260011200 | 260007103 | 1.67 | 75.1 | Palliative (P) | 2014-10-03 | 2014-10-26 | Rituximab | 02 | N | 260020087 | RITUXIMAB |
| 260011201 | 260007104 | 1.82 | 74.4 | Palliative (P) | 2018-04-12 | 2018-04-17 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260020093 | RITUXIMAB |
| 260011202 | 260007104 | 1.67 | 82.2 | Palliative (P) | 2013-08-01 | 2013-08-05 | Rituximab | 02 | N | 260020093 | RITUXIMAB |
| 260011203 | 260007106 | 1.75 | null | Palliative (P) | 2015-08-01 | 2015-08-04 | Rituximab | 02 | N | 260020105 | RITUXIMAB |
| 260011204 | 260013022 | 1.93 | 85.6 | Disease modification (D) | 2013-10-19 | 2013-11-20 | Rituximab | 02 | N | 260020105 | RITUXIMAB |
| 260011205 | 260007109 | 1.67 | 91 | Disease modification (D) | 2017-12-13 | 2017-12-20 | Rituximab (Maintenance) | Y | N | 260020111 | RITUXIMAB |
| 260011206 | 260007109 | 1.8 | null | Palliative (P) | 2015-10-17 | 2015-11-09 | Rituximab | null | null | 260020111 | RITUXIMAB |
| 260011207 | 260016044 | 1.79 | 74.7 | Disease modification (D) | 2014-11-02 | 2014-11-13 | Rituximab | N | N | 260020114 | RITUXIMAB |
| 260011208 | 260017615 | 1.59 | 0 | Palliative (P) | 2014-02-11 | 2014-06-27 | Rituximab (Maintenance) | N | N | 260020114 | RITUXIMAB |
| 260011209 | 260007110 | 1.8 | 83.7 | Disease modification (D) | 2017-02-17 | 2017-02-17 | Rituximab | 2 | N | 260020121 | RITUXIMAB |
| 260011210 | 260007110 | 1.76 | 71.4 | Palliative (P) | 2013-09-29 | 2013-10-01 | Rituximab (Maintenance) | 02 | N | 260020121 | RITUXIMAB |
| 260011211 | 260016045 | 1.76 | 83 | Palliative (P) | 2017-11-09 | 2017-11-09 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260020123 | RITUXIMAB |
| 260011212 | 260016045 | 1.68 | null | Neo-adjuvant (N) | 2016-09-15 | 2016-09-19 | Rituximab | N | N | 260020123 | RITUXIMAB |
| 260011213 | 260007112 | 1.57 | 81.2 | Curative (C) | 2014-06-17 | 2014-08-02 | Rituximab (Maintenance) | 02 | N | 260020124 | RITUXIMAB |
| 260011214 | 260007112 | 1.69 | null | Palliative (P) | 2017-12-24 | 2017-12-27 | Rituximab | 02 | N | 260020124 | RITUXIMAB |
| 260011215 | 260007112 | 1.57 | 93.8 | Curative (C) | 2017-11-24 | 2017-12-07 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 260020124 | RITUXIMAB |
| 260011216 | 260007112 | 1.75 | null | Disease modification (D) | 2017-01-22 | 2017-07-01 | Rituximab | 02 | N | 260020124 | RITUXIMAB |
| 260011217 | 260007112 | null | 90 | Palliative (P) | 2016-05-17 | 2016-05-30 | Rituximab (Maintenance) | 2 | N | 260020124 | RITUXIMAB |
| 260011218 | 260007113 | 1.57 | 115.4 | Disease modification (D) | 2014-04-10 | 2014-04-11 | Rituximab (Maintenance) | null | null | 260020141 | RITUXIMAB |
| 260011219 | 260007113 | 1.65 | null | Disease modification (D) | 2016-03-17 | 2017-06-20 | Rituximab | 02 | N | 260020141 | RITUXIMAB |
| 260011220 | 260007115 | 1.62 | 54.9 | Palliative (P) | 2015-12-31 | 2016-09-13 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 260020150 | RITUXIMAB |
| 260011221 | 260007115 | 1.7 | 56.4 | Disease modification (D) | 2017-12-29 | 2018-07-20 | Rituximab (Maintenance) | N | N | 260020150 | RITUXIMAB |
| 260011222 | 260007116 | 1.66 | null | Disease modification (D) | 2018-02-12 | 2018-04-10 | Rituximab | 02 | N | 260020157 | RITUXIMAB |
| 260011223 | 260007117 | 1.81 | 82.8 | Disease modification (D) | 2016-08-31 | 2016-09-09 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | Y | 260020157 | RITUXIMAB |
| 260011224 | 260007118 | 1.76 | 80.7 | Disease modification (D) | 2015-02-23 | 2016-03-17 | Rituximab | 02 | N | 260020159 | RITUXIMAB |
| 260011225 | 260007118 | 1.44 | 68 | Palliative (P) | 2016-02-29 | 2016-03-03 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260020159 | RITUXIMAB |
| 260011226 | 260007119 | 1.77 | null | Disease modification (D) | 2018-04-24 | 2018-05-01 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260020164 | RITUXIMAB |
| 260011227 | 260007119 | 1.78 | 75 | Disease modification (D) | null | 2014-04-13 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260020164 | RITUXIMAB |
| 260011228 | 260007120 | 1.72 | null | null | 2013-12-19 | 2013-12-26 | Rituximab (Maintenance) | N | null | 260020168 | RITUXIMAB |
| 260011229 | 260007121 | 1.82 | 80.5 | Disease modification (D) | 2017-04-09 | 2017-04-09 | Rituximab | 2 | N | 260020168 | RITUXIMAB |
| 260011230 | 260007122 | 0 | null | Curative (C) | 2015-07-13 | 2015-07-13 | Rituximab | 02 | N | 260020175 | RITUXIMAB |
| 260011231 | 260007124 | null | null | null | 2015-12-07 | 2016-06-07 | Rituximab (Maintenance) | N | N | 260020180 | RITUXIMAB |
| 260011232 | 260007125 | 1.65 | null | Palliative (P) | 2016-01-05 | 2016-02-10 | Rituximab (Maintenance) | N | N | 260020182 | RITUXIMAB |
| 260011233 | 260007125 | 1.65 | 0 | Disease modification (D) | 2017-12-07 | 2017-12-19 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260020182 | RITUXIMAB |
| 260011234 | 260007125 | null | 72.8 | Palliative (P) | 2014-05-24 | 2014-05-24 | Rituximab | 02 | N | 260020182 | RITUXIMAB |
| 260011235 | 260007126 | null | 77.5 | Disease modification (D) | 2018-08-28 | 2018-08-29 | Rituximab (Maintenance) | N | N | 260020188 | RITUXIMAB |
| 260011236 | 260007126 | 1.81 | 63.5 | Palliative (P) | 2016-02-22 | 2016-02-23 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260020188 | RITUXIMAB |
| 260011237 | 260007127 | 1.86 | null | Palliative (P) | 2014-07-05 | 2014-07-05 | Rituximab | 2 | N | 260020210 | RITUXIMAB |
| 260011238 | 260007129 | 1.69 | 89.3 | Adjuvant (A) | 2016-08-27 | 2016-08-28 | Rituximab (Maintenance) | N | N | 260020214 | RITUXIMAB |
| 260011239 | 260007131 | 1.8 | null | null | 2015-04-14 | 2015-04-16 | Rituximab | N | N | 260020215 | RITUXIMAB |
| 260011240 | 260007132 | 0 | null | Adjuvant (A) | 2015-08-05 | 2015-08-10 | Rituximab | 02 | N | 260020216 | RITUXIMAB |
| 260011241 | 260013040 | 1.7 | null | Palliative (P) | 2014-04-26 | 2014-04-27 | Rituximab (Maintenance) | 02 | null | 260020217 | RITUXIMAB |